Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / C••••••• T••••••••• L••••••

V••• B••••••••• Closes Acquisition of C••••••• T••••••••• L•••••• (CTL), Strengthening Functional Immune Monitoring Capabilities

Add-on acquisitionclosedadd-onannounced Apr 8, 2026closed Apr 8, 2026Fact
What happened
Target
C••••••• T••••••••• L••••••
Platform
V••• B•••••••••add-on basis: V••• B••••••••• is held by I••• P••• Capital (holding evidence https://ironpathcapital.com/portfolio/)
Control
Control
Share acquired
unknown
Industry
technology / technology
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
4 named
Buy side
Side not stated
  • M••• T•••••••Managementconfirmed
    ““CTL represents a highly strategic addition to the VION platform and strengthens our presence at a workflow-critical point in immune medicine,” said M••• T•••••••, Chief Executive Officer of V••• B•••••••••. ”Functional cellular immune monitoring is becoming increasingly central to translational res”
  • C••••••• T••••••••• L••••••Targetconfirmed
    “V••• B••••••••• Closes Acquisition of C••••••• T••••••••• L•••••• (CTL), Strengthening Functional Immune Monitoring Capabilities”
Evidence
“V••• B••••••••• Closes Acquisition of C••••••• T••••••••• L•••••• (CTL), Strengthening Functional Immune Monitoring Capabilities”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 16, 2026
V••• B••••••••• Closes Acquisition of C••••••• T••••••••• L•••••• (CTL), Strengthening Fun | Private Equity Intelligence | DFX